Buprenorphine, Naloxone Drug Combination MeSH Descriptor Data 2025

MeSH Heading: Buprenorphine, Naloxone Drug Combination
Tree Number(s): D03.132.577.249.150.500; D03.132.577.249.706.275; D03.605.497.150.500; D03.605.497.750.275; D03.633.400.686.150.500; D03.633.400.686.750.275; D04.615.723.795.150.500; D04.615.723.795.706.275; D26.310.352
Unique ID: D000069479
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000069479
Scope Note: A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.
Entry Term(s): Buprenorphine Naloxone; Buprenorphine Naloxone Drug Combination; Buprenorphine-Naloxone; Buprenorphine-Naloxone Combination; Buprenorphine-Naloxone Drug Combination; Suboxone
Pharm Action: Analgesics, Opioid
Narcotic Antagonists
Public MeSH Note: 2016; BUPRENORPHINE, NALOXONE DRUG COMBINATION was indexed under BUPRENORPHINE and NALOXONE 2006-2015
History Note: 2016 (2006)
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2019/03/27

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Heterocyclic Compounds [D03]
- Alkaloids [D03.132]
  - Opiate Alkaloids [D03.132.577]
    - Morphinans [D03.132.577.249]
      - Buprenorphine [D03.132.577.249.150]
        
        Buprenorphine, Naloxone Drug Combination [D03.132.577.249.150.500]

Heterocyclic Compounds [D03]
- Alkaloids [D03.132]
  - Opiate Alkaloids [D03.132.577]
    - Morphinans [D03.132.577.249]
      - Naloxone [D03.132.577.249.706]
        
        Buprenorphine, Naloxone Drug Combination [D03.132.577.249.706.275]
        
        Naltrexone [D03.132.577.249.706.550]

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, Bridged-Ring [D03.605]
  - Morphinans [D03.605.497]
    - Buprenorphine [D03.605.497.150]
      - Buprenorphine, Naloxone Drug Combination [D03.605.497.150.500]

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, Bridged-Ring [D03.605]
  - Morphinans [D03.605.497]
    - Naloxone [D03.605.497.750]
      - Buprenorphine, Naloxone Drug Combination [D03.605.497.750.275]
      - Naltrexone [D03.605.497.750.550]

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, Fused-Ring [D03.633]
  - Heterocyclic Compounds, 4 or More Rings [D03.633.400]
    - Morphinans [D03.633.400.686]
      - Buprenorphine [D03.633.400.686.150]
        
        Buprenorphine, Naloxone Drug Combination [D03.633.400.686.150.500]

Heterocyclic Compounds [D03]
- Heterocyclic Compounds, Fused-Ring [D03.633]
  - Heterocyclic Compounds, 4 or More Rings [D03.633.400]
    - Morphinans [D03.633.400.686]
      - Naloxone [D03.633.400.686.750]
        
        Buprenorphine, Naloxone Drug Combination [D03.633.400.686.750.275]
        
        Naltrexone [D03.633.400.686.750.550]

Polycyclic Compounds [D04]
- Polycyclic Aromatic Hydrocarbons [D04.615]
  - Phenanthrenes [D04.615.723]
    - Morphinans [D04.615.723.795]
      - Buprenorphine [D04.615.723.795.150]
        
        Buprenorphine, Naloxone Drug Combination [D04.615.723.795.150.500]

Polycyclic Compounds [D04]
- Polycyclic Aromatic Hydrocarbons [D04.615]
  - Phenanthrenes [D04.615.723]
    - Morphinans [D04.615.723.795]
      - Naloxone [D04.615.723.795.706]
        
        Buprenorphine, Naloxone Drug Combination [D04.615.723.795.706.275]
        
        Naltrexone [D04.615.723.795.706.550]

Pharmaceutical Preparations [D26]
- Drug Combinations [D26.310]

Buprenorphine, Naloxone Drug Combination Preferred

Suboxone Narrower

page delivered in 0.159s